West Pharmaceutical Services | WST - Cost Of Sales

Stock Price
292.13
Daily Change
-10.07 -3.33%
Monthly
19.17%
Yearly
36.85%
Q2 Forecast
299.61

West Pharmaceutical Services reported $548.5M in Cost of Sales for its fiscal quarter ending in March of 2026.





Cost Of Sales Change Date
Align Technology USD 363.97M 7.48M Dec/2025
Avanos Medical USD 94.9M 3.1M Dec/2025
Baxter International USD 2.4B 512M Dec/2025
Becton, Dickinson and Co. USD 2.84B 2.35B Dec/2025
Cerus USD 23.42M 3.61M Dec/2024
Charles River Laboratories USD 722.27M 28.81M Dec/2025
Cooper Companies USD 376.8M 87.4M Dec/2025
Dentsply International USD 518M 55M Dec/2025
Haemonetics USD 136.58M 4.01M Dec/2025
ICU Medical USD 337.72M 1.61M Dec/2025
Insulet USD 215.2M 19M Dec/2025
Integra LifeSciences USD 193.44M 1.62M Dec/2025
IQVIA Holdings USD 3.24B 518M Dec/2025
J&J USD 8.07B 103M Mar/2026
Medtronic USD 3.61B 83M Dec/2025
Merit Medical Systems USD 198.58M 838K Dec/2025
Neogen USD 112.2M 5.81M Dec/2025
OraSure Technologies USD 15.43M 113K Dec/2025
Quidel USD 448.8M 1.21B Dec/2025
Repligen USD 94.08M 5.79M Dec/2025
Rockwell Medical USD 21.28M 1.67M Jun/2024
Solventum Corp USD 971M 8M Dec/2025
STAAR Surgical USD 14.06M 2.8M Dec/2025
Terumo JPY 143.44B 15.47B Dec/2025
Utah Medical Products USD 3.78M 419K Dec/2025
West Pharmaceutical Services USD 548.5M 47.4M Mar/2026